UPDATED Aug 13, 2025
Explore the U.S. (NYSE and NASDAQ) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.
| Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ROIV | US$11.96 | 3.3% | 4.6% | US$7.9b | US$17.11 | PS351.2x | E34.0% | n/a | ||
MRUS | US$67.09 | 5.2% | 32.7% | US$4.8b | US$90.40 | PS90.2x | E45.8% | n/a | ||
BBIO | US$50.40 | 2.7% | 107.8% | US$9.4b | US$62.43 | PS40.9x | E69.8% | n/a | ||
MEDP | US$468.00 | 1.9% | 21.5% | US$12.9b | US$410.27 | PE31.4x | E8.6% | n/a | ||
SHC | US$15.72 | 5.8% | 6.8% | US$4.2b | US$16.00 | PE186.3x | E61.1% | n/a | ||
DNLI | US$14.81 | 12.0% | -34.1% | US$1.9b | US$31.75 | PB2.1x | E27.6% | n/a | ||
PTCT | US$48.17 | 6.4% | 51.6% | US$3.6b | US$68.31 | PE6.1x | E-37.5% | n/a | ||
JAZZ | US$117.12 | 3.3% | 7.3% | US$6.9b | US$183.00 | PS1.7x | E54.2% | n/a | ||
AXSM | US$109.39 | 4.0% | 29.0% | US$5.3b | US$176.95 | PS11x | E67.0% | n/a | ||
ALKS | US$28.63 | 4.4% | 8.8% | US$4.5b | US$41.50 | PE13.6x | E-5.4% | n/a | ||
ELAN | US$17.81 | 2.2% | 26.5% | US$8.7b | US$18.18 | PE20.4x | E-4.4% | n/a | ||
PCVX | US$31.43 | 4.8% | -59.2% | US$3.9b | US$114.88 | PB1.3x | E15.9% | n/a | ||
STOK | US$16.91 | 25.0% | 21.0% | US$738.7m | US$23.89 | PE17.6x | E-24.7% | n/a | ||
INSM | US$122.87 | 0.7% | 64.1% | US$25.8b | US$143.18 | PS65.2x | E64.6% | n/a | ||
KRYS | US$149.34 | 4.0% | -20.7% | US$4.2b | US$205.50 | PE29.5x | E33.8% | n/a | ||
VKTX | US$41.27 | 3.5% | -29.1% | US$4.5b | US$89.28 | PB5.8x | E-9.0% | n/a | ||
SRPT | US$20.40 | 8.5% | -84.7% | US$1.8b | US$23.52 | PB1.5x | E48.6% | n/a | ||
RVMD | US$36.09 | 2.3% | -15.3% | US$6.6b | US$72.00 | PB3.6x | E24.3% | n/a | ||
CRNX | US$30.09 | 5.7% | -41.5% | US$2.7b | US$69.38 | PS2035.7x | E34.8% | n/a | ||
VCYT | US$30.68 | 6.6% | -1.6% | US$2.3b | US$39.75 | PE91.7x | E36.6% | n/a | ||
GILD | US$120.14 | 0.1% | 62.0% | US$148.9b | US$122.53 | PE23.6x | E13.0% | 2.6% | ||
ZLAB | US$35.63 | 3.8% | 119.3% | US$3.8b | US$56.15 | PS9.2x | E68.6% | n/a | ||
STVN | US$22.36 | 2.4% | 12.2% | US$6.0b | US$28.62 | PE38.8x | E19.2% | 0.3% | ||
EXEL | US$38.47 | 1.4% | 46.3% | US$10.2b | US$44.74 | PE17.2x | E19.9% | n/a |